Patent: 10,307,483
✉ Email this page to a colleague
Summary for Patent: 10,307,483
| Title: | Pharmaceutical formulations and methods of making the same |
| Abstract: | The invention relates to the formulation of pharmaceutical compositions of etanercept. The invention also relates to methods of removing buffer and of formulating pharmaceutical compositions of etanercept. |
| Inventor(s): | Goss; Monica (Newbury Park, CA), Ball; Nicole (Thousand Oaks, CA) |
| Assignee: | AMGEN INC. (Thousand Oaks, CA) |
| Application Number: | 15/958,261 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,307,483
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | November 02, 1998 | 10,307,483 | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | May 27, 1999 | 10,307,483 | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | September 27, 2004 | 10,307,483 | 2038-04-20 |
| Immunex Corporation | ENBREL | etanercept | Injection | 103795 | February 01, 2007 | 10,307,483 | 2038-04-20 |
| Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | September 14, 2017 | 10,307,483 | 2038-04-20 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,307,483
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2017345490 | ⤷ Start Trial |
| Brazil | 112019007858 | ⤷ Start Trial |
| Canada | 3040899 | ⤷ Start Trial |
| Chile | 2019001053 | ⤷ Start Trial |
| China | 109982685 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
